Spinal Modulation Neurostimulator System in the Treatment of Chronic Pain

Does the Spinal Modulation Neurostimulator System provide safe and efficacious pain relief in people with chronic pain?

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12609000739213

Enrollment

Registered

2009-08-26

Start date

2009-09-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the current study is to determine the safety and efficacy of a neuromodulation therapy in the treatment of chronic pain. We hypothesize that this study will demonstrate safe delivery of therapy which will result in significant pain relief.

Interventions

This study uses an invasive neurostimulation device that is used for up to 24 hours per day. Duration of treatment in this study is 3-10 days. Part of the device is implanted in the patient and the device is controlled with a hand held remote. The amount of therapy used throughout the day is patient controlled.

Study design

Allocation

Non-randomised trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Chronic pain 2. Failed conservative treatments

Exclusion criteria

Primarily axial back pain

Outcome results